Early childhood infections significantly increase the risk of severe infections and antibiotic use later in childhood, highlighting the importance of early prevention and monitoring.
Causaly secures $60 Million in series B funding – Pharmaceutical Technology
AI technology is used for drug discovery. Image credit: LookerStudio via Shutterstock Causaly, a company that uses AI for biomedical research, has closed a $60m
July 14, 2023